How has the pandemic affected you, personally and professionally?

Video

Dr. Breazzano discusses the professional challenges and personal effects he faced during the beginning of the COVID-19 pandemic.

How has the pandemic affected you, personally and professionally?

Mark Breazzano, MD: I think the pandemic, I would say professionally and personally was definitely scary in the beginning.

I do feel like, in some ways, it was a little bit of a unique experience. As I was finishing up my fellowship in New York City, was one of the early hotspots of the pandemic in the United States, certainly, there were other hotspots around the same time, including Italy and other places that were hit particularly hard. And we still didn't really understand that much of the virus back then. And so going and treating these patients, I think, was obviously, as ophthalmologists, we're not necessarily in the COVID wards, although some of my colleagues certainly did get pulled to those areas, which certainly can be a terrifying experience for a virus that we know so little about.

I think that part was a little bit disconcerting at the time, but also, I think it was very rewarding, being able to take care of patients while the crisis was certainly happening. And it was a little bit nerve-wracking, too, because all of a sudden, there was this decrease again, with those, for example, we weren't seeing retinal detachments or other emergencies that we know are constantly coming in—it can vary a little bit, but generally speaking, they should be coming in—and we would go, you know, days without seeing one. It made you wonder how many people might be staying at home, afraid to come in, because they were afraid of getting infected. And so I think that's played a big role in just making sure that all of us are treating our patients.

And on a personal level, I think that, you know, there is this concern for

transmitting an infection not only to ourselves, but to patients and to staff. And so I think, just that risk of sort of being around in that setting, I think was a little unnerving for a lot of us. But, you know, the comfort level certainly improved, I think, as things sort of progressed.

Related Content: Ophthalmology | Retinal Surgery | Imaging

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Recent Videos
Carl Danzig, MD, director of vitreo-retinal services at the Rand Eye Institute in Deerfield Beach, Florida, shared an update on his research in OCS-01 drops for diabetic macular edema during ARVO
Jennifer Lim, MD, FARVO, FASRS, from the University of Illinois at Chicago, discussed her ARVO presentation on sickle cell retinopathy. She highlighted improvements in retinal surgery techniques and instrumentation.
At ARVO 2025, Christine Kay, MD, shares interim results from the PRISM trial population extension cohort
ARVO 2025: Rishi Singh, MD, discusses real-world clinical outcomes in patients with DME
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Abby Markward and Hattie Hayes discuss the ASCRS Annual Meeting, the ASOA Annual Meeting, and the Retina Day event.
© 2025 MJH Life Sciences

All rights reserved.